Endothelial Health VENDYS offers an FDA-cleared, office-based vascular reactivity test that detects endothelial dysfunction in 5 minutes, presenting an actionable VRI score that can drive physician adoption and patient engagement for cardiovascular risk assessment.

Reimbursement Advantage Testing is reimbursable under Medicare and private payers, creating a clear financial case for clinics to adopt VENDYS and integrate into standard cardiometabolic risk workflows.

Clinical Adoption With a simple protocol and immediate, colorful reports, the device supports clinician motivation to improve adherence to therapies and lifestyle changes, offering a compelling value proposition for primary care and specialty practices.

SMB Footprint Small team size (2-10 employees) suggests a need for scalable partner programs, channel partnerships, and white-label or distribution arrangements to accelerate market reach.

Tech & Growth Fit Digital marketing and cloud-based tech stack indicate opportunities to leverage existing channels for lead generation, including targeted ads and professional networks, plus potential integration with health IT systems for seamless data flow.